Jfs Wealth Advisors, LLC Novo Cure LTD Transaction History

Jfs Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$63.98 - $85.37 $63 - $85	1 New	1 $0
Q2 2022 Aug 02, 2022	SELL	$56.6 - $89.9 $1,641 - $2,607	-29 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$60.15 - $84.52 $4,451 - $6,254	-74 Reduced 71.84%	29 $2,000
Q4 2021 Feb 03, 2022	BUY	$75.08 - $121.99 $225 - $365	3 Added 3.0%	103 $8,000
Q3 2021 Nov 09, 2021	BUY	$116.17 - $194.55 $11,617 - $19,455	100 New	100 $12,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.